CoChat

Optimizing risk-based breast cancer screening policies with reinforcement learning

Open access

Published version of a preprint

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

Screening programs must balance the benefit of early detection with the cost of overscreening. Here, we introduce a novel reinforcement learning-based framework for personalized screening, Tempo, and demonstrate its efficacy in the context of breast cancer. We trained our risk-based screening policies on a large screening mammography dataset from Massachusetts General Hospital (MGH; USA) and validated this dataset in held-out patients from MGH and external datasets from Emory University (Emory; USA), Karolinska Institute (Karolinska; Sweden) and Chang Gung Memorial Hospital (CGMH; Taiwan). Across all test sets, we find that the Tempo policy combined with an image-based artificial intelligence (AI) risk model is significantly more efficient than current regimens used in clinical practice in terms of simulated early detection per screen frequency. Moreover, we show that the same Tempo policy can be easily adapted to a wide range of possible screening preferences, allowing clinicians to select their desired trade-off between early detection and screening costs without training new policies. Finally, we demonstrate that Tempo policies based on AI-based risk models outperform Tempo policies based on less accurate clinical risk models. Altogether, our results show that pairing AI-based risk models with agile AI-designed screening policies has the potential to improve screening programs by advancing early detection while reducing overscreening.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-021-01599-w

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Cited by

See all 103

Metadata

Authors
Yala, A., Mikhael, P. G., Lehman, C., Lin, G., Strand, F., Wan, Y.-L., Hughes, K., Satuluru, S., Kim, T., Banerjee, I., Gichoya, J., Trivedi, H., & Barzilay, R.
Affiliations
  • Massachusetts Institute of Technology (US)
  • Harvard University (US)
  • Chang Gung University (TW)
  • Karolinska University Hospital (SE)
  • Medical University of South Carolina (US)
  • Emory University (US)
  • Georgia Institute of Technology (US)
  • Mayo Clinic (US)
Corresponding author
Yala, Adam
Venue
Nature Medicine
Published
2022-01
Volume
28
Issue
1
Pages
136-143
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W4226269440
Cited by
103
References
51
Citations by year
2026: 18 · 2025: 23 · 2024: 27 · 2023: 22 · 2022: 13
FWCI
6.97
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Medicine (publishedVersion)
  • Research Square (acceptedVersion, cc-by)
  • PubMed (publishedVersion)
  • DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
Funders
  • Susan G. Komen
  • MIT J-Clinic Quanta Computing Anonymous Foundation
Topics
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Digital Radiography and Breast Imaging
Keywords
breast cancer screening, reinforcement learning, personalized screening, overscreening, early detection, mammography, screening frequency, clinical risk model, screening costs
MeSH terms
Artificial Intelligence, Breast Neoplasms, Female, Humans, Mammography, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Optimizing risk-based breast cancer screening policies with reinforcement learning. https://app.cochat.ai/papers/10.1038/s41591-021-01599-w
The paper
Yala, A., Mikhael, P. G., Lehman, C., Lin, G., Strand, F., Wan, Y.-L., Hughes, K., Satuluru, S., Kim, T., Banerjee, I., Gichoya, J., Trivedi, H., & Barzilay, R. (2022). Optimizing risk-based breast cancer screening policies with reinforcement learning. Nature Medicine. https://doi.org/10.1038/s41591-021-01599-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.